Cannabidiol is a non-intoxicating phytocannabinoid from Cannabis sativa that modulates endocannabinoid, serotonergic and GABAergic signalling, approved pharmaceutically for treatment-resistant childhood epilepsy syndromes and widely used in consumer wellness products. Simson Pharma's Cannabidiol reference standard and impurities support pharmacopoeial potency testing and residual cannabinoid-profile analysis.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cannabidiol Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.